Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

BMS sets up US research university initiative

August 4, 2014 Medical Communications, Research and Development, Sales and Marketing BMS, academia, university

News

ABPI president: NICE needs political reform

August 1, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, NICE, Pfizer, jonathan emms, vba

Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …
Feature

Minister calls for end of animal testing

August 1, 2014 Research and Development, Sales and Marketing Animal testing

British MP Norman Baker has called for an end to all animal testing in the UK and promised to increase …
News

Genomes Project gains £300m UK funding boost

August 1, 2014 Medical Communications, Research and Development, Sales and Marketing Genomics england, Illumina, NHS England, david cameron, genomes

A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister …
News

Boehringer’s Striverdi gains FDA approval

August 1, 2014 Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol

Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …
News

AstraZeneca’s second quarter beats estimates

July 31, 2014 Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer

AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …
News

‘Smart pill’ creator gains new funding

July 31, 2014 Medical Communications, Research and Development, Sales and Marketing digital medicine, proteus, smart pills

Proteus Digital Health has raised $172 million to help develop its new brand of smart pills that can help patients …
News

Cause of rare childhood cancer discovered

July 31, 2014 Research and Development, Sales and Marketing Cancer, RMS, YAP, childhood cancer

Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS). Around 60 …
News

Tonic expands leadership team with two new hires

July 31, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Tonic Life Communications, the PR arm for Huntsworth Health, has added Tracey Carey as its new head of consumer and …
Appointment

NICE won’t back Revlimid in new setting

July 31, 2014 Medical Communications, Sales and Marketing Celgene, NICE, Revlimid, Thalidomide, multiple myeloma

NICE has once again said it does not think that Celgene’s rare cancer drug Revlimid should be used on the …
News

Dementia diagnoses on the rise

July 30, 2014 Medical Communications, Research and Development, Sales and Marketing Alzheimer's, david cameron, dementia

The number of patients in England diagnosed with dementia has increased by 62% over seven years according to provisional figures …
News

MKTXS appoints Dr Steven Bradshaw as director

July 30, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director. Market …
Appointment

AstraZeneca secures respiratory drugs from Almirall

July 30, 2014 Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs

AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …
News

Amgen to wield axe on 2,900 jobs

July 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …
News

Pfizer revenue drops, but new cancer drugs shine

July 29, 2014 Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra

Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026